Proceedings of the First Hong Kong (Asia PacFfic) Medical Informatics Conference
|
|
- Gwendoline Curtis
- 6 years ago
- Views:
Transcription
1 HK Proceedings of the First Hong Kong (Asia PacFfic) Medical Informatics Conference Hong Kong Polytechnid 6-18 November 1990 Edited by ANTHONY J HEDLEY Department of Community Medicine University of Hong Kong WONG CHUN POR Hong Kong Society of Medical Informatics Conference Organizing Committee Chairman: AJ Hediey Vice Chairman: CP Wong Secretary/Treasurer: YW Ho. Members; KK Cheng Wilson Chick-. William Chiu.. KJ Goulding - ' i :.,. ^ David Leung ; :.- :{ ' " Raymond Leung Debbie Shum Alfred Tang Douglas Tung CM Wong Published by the Hong Kong Society of Medicaf informatics and the Hong Kong Computer Society isbn: ' ' '
2 "7 EProEIVnOLOGICAL AND RESOURCE DATA NEEDED FOR AN ECONOiVnC EVALUATION STUDY IN PATIENTS WITH GASTRIC ULCER ON NSAIDs RP Knill-Jones, HS Kohli Dept of Public Health, University of Glasgow, Scotland. MF Drummond, L Davies Centre for Health Economics, University of York, England. ABSTRACT Increasing use of nonsteroidal anti-inflammatory drugs (NSAIDs) results in clinically significant complications, including gastric ulcers which may bleed or perforate. This study examines the information needed to undertake an economic evaluation of misoprostol in preventing gastric ulcers (GUs) in patients receiving NSAIDs. It also identifies the deficiencies in data available to the UK National Health Service (NHS) with respect to economic assessments, as existing large epidemiological data bases do not contain all the information needed for an economic evaluation. Costs of medical treatments and procedures are rarely available in the NHS and had to be measured in a special study. A detailed analysis of a sample of relevant admissions of patients with GI disease in Glasgow in 1987 was necessary to help in the interpretation of national epidemiological data, and to assess resources used in hospital. Structured telephone surveys of general practitioners in Glasgow and Birmingham were undertaken to provide estimates of the resources used in managing these patients in the community. 1. INTRODUCTION There is a worldwide use of non-steroidal anti-inflammatory agents (NSAIDs) in the elderly. 1
3 particularly in Europe. Over the past 8 years prescriptions for NSAIDs in the UK have increased by 64%, in 1986 reaching 23 million [1,2]. Concurrently there has been a rise in peptic ulcer perforation rates among women. This has occurred in spite of a fall in total hospital admissions for ulcer in both sexes, and a steady fall in ulcer perforations in males [3]. The rise in perforation rate in women has been accompanied by an increase in mortality for this complication of 18% in women aged over 75, compared with a fall of 23% in mortality for males over the same period [4]. Some, but not all, of these features have been noted in the USA [5]. A retrospective case-control study on bleeding peptic ulcers admitted to Nottingham hospitals showed a relative risk of 2.7 (95% confidence limits{cl} 1.7 to 4.4) for NSAID use in people over 60 [4]. The same community showed a similar relative risk for aspirin [8]. In contrast, a prospective study on ulcer perforation in the USA gave a relative risk of 1.6 (CL ) suggesting no association [9]. Two others gave relative risks of 2.5 (CL ) [10] and 4.7 (CL ) [11] indicating, on balance, an association between NSAID use and ulcer. The precise extent of the risk of ulcer from NSAIDs is uncertain [6,7] and firm evidence that the observed association is a causal one is lacking. Ulcer-like symptoms occur in up to half the patients taking NSAIDs [12]. Over a three-month period of treatment, about one-third of patients on NSAIDs develop GI symptoms, and 1% may develop a major complication [13,14]. The situation is further complicated in that the use of NSAIDs amongst the over 75's seems to mask ulcer symptoms. This may lead to a late presentation of complicated peptic ulcer and a resulting poorer prognosis [15,16]. Drugs can be used to prevent GI complications from NSAIDs and several have been evaluated [1,17]. One of them is misoprostol, which is effective in preventing gastric mucosal lesions [18] and in reducing transfusion requirements in upper gastro-intestinal bleeding [19]. The prevalence of gastric mucosal erosions and ulcers (confirmed by endoscopy) is high following NSAID use. It was 22% in one clinical trial [18], 20% in asymptomatic patients with rheumatoid arthritis [20] and if anaemia was also present, higher at 37% [20]. Duodenal ulcer rates in the same studies are much lower, the correspondingfiguresranging between 2% and 4% [18,20], and up to 8% [1]. Ranitidine, an blocker, is effective in reducing 2
4 duodenal inflammation when prescribed concomitantly with NSAIDs [1]. However, the same smdy failed to demonstrate a significant effect on gastric ulcers or erosions [1]. Medical decision analysis [21-23] can be used to elucidate the effectiveness of interventions in populations of patients. This allows an economic evaluation of the clinical decision to give prophylaxis or not. Economic evaluation has also been undertaken for treatment of Rheumatoid Arthritis [24], for maintenance therapy of duodenal ulceration using Ho antagonists [25-28], and for ulcer surgery [29]. Increasingly health care resources in the UK are stretched in the face of competing demands for their use. It is now necessary to show not only that therapies are effective, but also that they represent a good use of resources. Concerns about the value for money from prophylaxis of NSAID-associated ulcers were recently raised in two editorials [30,31]. For all these reasons it is becoming more important to use medical decision analysis and economic evaluation in health care. This paper draws attention to the lack of readily available data to enable an accurate economic evaluation to be carried out in the UK National Health Service (NHS). It also outlines the steps needed to complete a decision analysis of the prevention of NSAID - associated ulcers. 2. METHODS A decision tree demonstrating the process of care for a patient who developed symptoms while taking NSAIDs was drawn up and its structure agreed. Each circular node represents a chance node at which the probabilities of a patient following one or other branch need to be obtained. 3
5 Figure 1. Decision tree PATIENT WITH ABDOMINAL PAIN ON NSAIDs No Ulcer Ulcer Ambulatory care Hospital Admission 1 Medical Treatment Surgical Treatment 3 4 The numbers 1-4 at the bottom of the tree show that different costs had to be calculated for patients following each path. This process identified the two kinds of information that were needed to allow a full decision analysis to be performed. First the probabilities of certain events are required, for example: - the chance of developing a gastric ulcer, the subsequent chance of a severe bleed or perforation, and the probability that certain investigations would be arranged by the general practitioner. The second type of information needed was the cost of 4
6 attendance at a general practitioner's surgery, the cost of an endoscopy, and the cost of a stay in a hospital ward. 3. RESULTS 3.1 SOURCES OF PROBABILITIES The risk of developing a gastric ulcer in a patient with symptoms, if untreated, was about 22% [18]. The risk for a patient of a hospital admission with a complication (5.34%) was obtained from a large-scale study in general practice [32]. This provided approximate estimates because of differences in diagnostic classification which were broader than that of gastric ulcer. The tree shows that patients admitted to hospital could be kept in a medical ward, particularly if they had bled, or to a surgical ward if they had perforated. The relevant proportions were obtained from a Scottish data set covering all hospital discharges (680,000 annually), and from an equivalent data set in the West Midlands region in England (5(X),000 annually). There were 3867 discharges with gastric ulcer as a principal diagnosis in Scotland for the three years % of these cases, with an average age of 62.5 years, had operations and their mean length of stay was 9.5 days. The remainder, who were treated medically, were aged 65.3 and had a mean length of stay of 10.4 days. It was important to distinguish those receiving medical care from those having surgical care because of the differing costs. Special analyses had to be undertaken to provide information on type of care from the very large National or Regional data sets, which are readily available for this purpose and which also provided some data for the cost calculations. Another set of probabilities related to the investigation sti-ategy that general practitioners would adopt when faced with a patient with symptoms on NSAIDs. Ideally tiiis information might have been obtained by follow-up of a large number of patients on NSAIDs, some of whom could develop ulcer, but this would have been very expensive and time-consuming. Therefore telephone surveys with general practitioners in Glasgow and in Birmingham were conducted by one of the authors. Figure 2 on the next page gives an outline of the structure of the interview and also shows the items whosefrequencyof utilisation needed to be obtained. 5
7 Figure 2. GP telephone interviews. No ulcer Introduction Persistent / Symptomatic symptoms ( P?!' "t Investigate X Initsal actions Ulcer INFORMATION NEEDED Treatment Recall rate Endoscopy X-Ray Treatment Recall rate OP Appt. Biopsy Repeat endoscopy Recall rate The interviews provided estimates of the number of patients' attendances at a doctors' surgery, the probabilities of whether a directly referred investigation would first be by endoscopy or by X-Ray, or of a hospital appointment for a consultant opinion to obtain an endoscopy, the probability of which further investigations would be arranged should an ulcer be found, and the numbers of additional surgery visits during this period. Also needed for some patients, but not shown in figure 2, were the numbers of follow-up visits to hospital and to general practice after a hospital admission with a complication. 6
8 The final set of probabilities that were required related to the investigations completed and to the use of hospital-based resources, for example the proportion of patients having blood transfusions, the average number of bed-days in intensive care and the average mix of tests done. Such information is not routinely available in the NHS for different diagnoses, neither for'clinical specialty or diagnosis-related groups, nor even for an entire hospital. Identification of these probabilities was done by case review. A random sample of 778 patients admitted to Glasgow hospitals was identified from all admissions (4355) in 1987 with gastrointestinal diagnoses. These represented 3586 individuals from which the sample was drawn. Case notes in the 5 main Glasgow hospitals were examined to assess the resources used, only 17 (2.2%) being unavailable during the three months needed to complete the review. Analysis of this data demonstrated that 53% of patients over 60 years of age in a surgical ward received a blood transfusion, 91 % an endoscopy, 18% a Barium meal and that patients spent an average of 0.6 days in intensive care. 3.2 COSTS NHS routine data sources provided costs of only a few items needed for the study. The cost of all investigations (endoscopies, X-Rays, etc.) had to be estimated by a special survey as these individual items are not costed separately in the NHS. This involved an assessment of the staff time, drugs and other items needed for an X-Ray, which in turn were costed and the figure of 37 calculated (Table 1). The cost of a bed-day in intensive care was not available fi-om the NHS at the time and a private sector charge had to be used as an estimate. 7
9 TABLE 1 ^ Item Source of Cost to Source of valuation nearest utilisation estimate Attendance at CP's surgery NHS 6 GP survey Attendance at Out Patient Dept NHS 14 GP survey Endoscopy Special survey 84 GP survey Biopsy Special survey 44 GP survey/ consultant opinion X-Ray Barium meal Special survey 37 GP survey/ case review X-Ray Barium enema Special survey 56 GP survey/ case review Ambulance journey (Emergency) NHS 17 Case review Hospital 'hotel' cost per day NHS 51 NHS/ National data bed-days Intensive care per day Private sector 330 NHS/ Case review bed-days Surgery* Special survey 352 NHS/ National data bed-days Medical care* Special survey 52 NHS/ National data bed-days Blood transfusion (average ulcer) Special survey 89 Case review Drug cost - H2 antagonist 6 weeks NHS 45 Consultant Drug cost - misoprostol 400jig/day NHS (3 months) 39 Consultant^ Study design. *in addition to investigations, day cost and follow-up costs Cost data were combined with the utilisation data to give the cost of the four different paths through the decision tree for Scotland. The results of the full decision analysis, including the data from the West Midlands, are presented in detail elsewhere [33]. Misoprostol will prevent 75% of the ulcers when given in a 400 jig daily dose [18]. The decision analysis shows (summarised over the page in Table 2) that under this set of assumptions the reduction in the numbers of ulcers and their associated high costs is greater than the additional cost of treating 8
10 patients with misoprostol. On balance there are cost savings that will arise from the use of this drug to prevent ulcer as shown by the average cost per case in Table 2. In other words the additional cost of misoprostol is more than balanced by the expected savings from the substantial reduction in the number of ulcers. TABLE 2 Tree branch Cost per case for 3 months (Scotland) (nearest ) (Figurel) No misoprostol misoprostol 1 No ulcer Ambulatory ulcer care Medical admission Surgical admission Average cost per case DISCUSSION This study underlines the difficulty in obtaining cost and other data from existing NHS sources to provide the information needed for decision analysis. Ideally all the information should be readily available from the NHS. This is not so now, though may improve as reforms to the NHS become effective. At present most effort is being directed towards preparing contacts between the purchasers of health care (the NHS health boards) and the providers (hospitals, some general practitioners). In the absence of detailed cost data these 9
11 contracts can only be given in the most general of terms. Tfte easy availability of the data needed to undertake the many necessary economic evaluations of activities in the NHS remains an objective for the future. 5. ^ REFERENCES 1. EhsanuUah RSB, Page MC, Toldesley G, Wood JR. Prevention of gastro-duodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Br Med J 1988; 297: Walt R, Katchinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: Coggon D, Lambert P, Langman MJS. 20 years of hospital admissions for peptic ulcer in England and Wales. Lancet 1981; 1: Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: Kurata JH, Haile BM. Epidemiology of peptic ulcer disease. Clin Gastro 1984; 13: Doherty M. Non-steroidal anti-inflammatory drugs in patients with peptic ulcer disease: to be considered in certain circumstances. Br Med J 1989; 298: Hawkey C. Non-steroidal anti-inflammatory drugs in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit. Br Med J 1989; 298: Faulkner G, Prichard P, Somerville K, Langman MJS. Aspirin and bleeding ulcers in the elderly. Br Med J 1988; 297:
12 9. Jick SS, Perera DR, Walker AM, Tick H. Non-steroidal anti-inflammatory drugs and hospital admissions for perforated peptic ulcer. Lancet 1987; ii: Hillman AL, Bloom BS. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking non-steroidal anti-inflammatory drugs. Arch Int Med 1989 ;149: Giffin MR, Ray WA, Shaffner W. Non-steroidal anti-inflammatory drug use and deaths ii-om peptic ulcer in elderly persons. Ann Int Med 1988; 109: Coles LS, Fries JF, Kraines RG, Roth SH. From experiment to experience: side effects of non-steroidal anti-inflammatory drugs. Am J Med 1983; 120: Husby G, Holme I, Rugstad HE, Herland OB, Giercksky K-E. A double-blind multicentre trial of peroxicam and naproxin in osteoarthritis. Clin Rheumatol 1986; 5: Giercksky K-E, Husby G, Rugstad HE, Revhaug A. Epidemiology of NSAIDinduced GI problems and the role of cimetidine in their prevention. Aliment Pharmacol Therap 1988; 2 (suppl 1): Skander MP, Ryan FP. Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. Br Med J 1988; 297: Armsti-ong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987; 28: Watkinson G, Hopkins A, Akbar FA. The therapeutic efficacy of misoprostol in peptic ulcer disease. Postgrad Med J 1988;64: Suppl 1, Graham DY, Agrawal NW, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind placebo-controlled trial. Lancet 1988; 2:
13 19. Birnie GD. Akbar FA. Shroff NE, Shelton JR, Watkinson G. A double blind comparative study of misoprostol with placebo in acute upper GI bleeding. Int Gastroent 1988; Vol 1: r" Upadhyay R, Taha AS, Sturrock RD, Russell RI. Misoprostol and ulcer prophylaxis. Lancet 1989; i: Weinstein MC, Fineberg HV. Clinical Decision Analysis. Philadelphia: WB Saunders, Carrin G. Economic evaluation of health care interventions: a review of alternative methods. Soc Sci Med 1984; 19: Macartney FJ. Diagnostic logic. Br Med J 1987; 295: Thompson MS, Read JL, Hutchings CH, Paterson M, Harris ED. The cost effectiveness of Auranofm: results of a randomised clinical trial. J Rheumatol 1988; 15: Fox N, Morton RE, Jacobs J. The cost-effectiveness of maintenance therapy for duodenal ulceration with an H2 antagonist. Aliment Pharmacol Therap 1988; 2: Sitonen H, Alander V. Estimating the cost-effectiveness of three drugs in the treatment of duodenal ulcers. 4th annual meeting of the International Society of Technology Assessment in Health Care. Boston Navarro RP, Blissenbach HP. Using H2 antagonist "cost of therapy" data to make formulary decisions within a managed health care system. Medical Interface 1988; March: Weisbrod BA. Economic approaches to evaluating a new medical technology: the drug cimetidine. In AJ Culyer and B Horisberger. Economic and medical evaluation of health care technologies. Berlin: Springer-Verlag,
14 29. Culyer AJ, Maynard AK. Cost-effectiveness of duodenal ulcer treatment. Soc Sci Med 1981; 15C: Editorial. Lancet 1988; 2: Roth SH. Non-steroidal anti-inflammatory drugs: Gastropathy, deaths and medical practice. Ann Int Med 1988; 109: Royal College of General Practitioners, OPCS, DHSS. Morbidity Statistics from General Practice HMSG Series MB5 No. 1, London, Knill-Jones RP, Drumm^ond M, Kohli H, Davies L. Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. Postgrad Med J 1990; 66: ACKNOWLEDGEMENTS We are grateful to the Information and Statistics Division of the Common Services Agency of the Scottish Health Services, the Information Services Department of the Greater Glasgow Health Board, and the Statistics Department of the West Midlands Regional Health Authority for supplying data. We are also grateful to GPs in Glasgow and in Birmingham for their opinions on management and to G.D.Searle, UK, forfinancialsupport. 13 i
patients with arthritis receiving non-steroidal anti-inflammatory drugs
Postgrad Med J (1990) 66, 639-646 The Fellowship of Postgraduate Medicine, 1990 Points of View Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory
More informationIbuprofen versus other non-steroidal anti-in ammatory drugs: use in general practice and patient perception
Aliment Pharmacol Ther 2000; 14: 187±191. Ibuprofen versus other non-steroidal anti-in ammatory drugs: use in general practice and patient perception C. J. HAWKEY 1,D.J.E.CULLEN 1,9,G.PEARSON 1,S.HOLMES
More informationManagement of dyspepsia and of Helicobacter pylori infection
Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia
More informationScottish Medicines Consortium
Scottish Medicines Consortium ketoprofen/, 100mg/20mg; 200mg/20mg modified release capsules (Axorid ) No. (606/10) Meda Pharmaceuticals 05 February 2010 The Scottish Medicines Consortium (SMC) has completed
More informationNo Association between Calcium Channel Blocker Use and Confirmed Bleeding Peptic Ulcer Disease
American Journal of Epidemiology Copyright 1998 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 148, No. 4 Printed in U.S.A. A BRIEF ORIGINAL CONTRIBUTION No
More informationIndigestion (dyspepsia)
Commissioning pathways Indigestion (dyspepsia) Supplementary information to be read in conjunction with the pathway Reference Supplementary Information 1.1 Symptom Description Annual incidence 40%. Prevalence
More informationAudit of mortality in upper gastrointestinal bleeding
Postgraduate Medical Journal (1989) 65, 913-917 Medical Audit Audit of mortality in upper gastrointestinal bleeding B.D. Katschinski', R.F.A. Logan2, J. Davies3 and M.J.S. Langman4 'Division of Gastroenterology,
More informationReview Article. NSAID Gastropathy: An Update on Prevention. Introduction. Risk Factors. Kam-Chuen Lai
Review Article NSAID Gastropathy: An Update on Prevention Kam-Chuen Lai Abstract: Keywords: Adverse reactions to non-steroidal anti-inflammatory drugs (NSAIDs) are common. Upper gastrointestinal complications
More informationSELECTED ABSTRACTS. Figure. Risk Stratification Matrix A CLINICIAN S GUIDE TO THE SELECTION OF NSAID THERAPY
SELECTED ABSTRACTS A CLINICIAN S GUIDE TO THE SELECTION OF NSAID THERAPY The authors of this article present a 4-quadrant matrix based on 2 key clinical parameters: risk for adverse gastrointestinal (GI)
More informationGastrointestinal Safety of Coxibs and Outcomes Studies: What s the Verdict?
Vol. 23 No. 4S April 2002 Journal of Pain and Symptom Management S5 Proceedings from the Symposium The Evolution of Anti-Inflammatory Treatments in Arthritis: Current and Future Perspectives Gastrointestinal
More informationHave COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
et al. DOI:10.1111/j.1365-2125.2003.02012.x British Journal of Clinical Pharmacology Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs? Mary Teeling, Kathleen Bennett
More informationPerforated duodenal ulcer: which operation?
The Ulster Medical Journal, Volume 56, No. 2, pp. 130-134, October 1987. Perforated duodenal ulcer: which operation? P J Gill, C F J Russell Accepted 7 September 1987. SUMMARY Between January 1968 and
More informationSurvey on repeat prescribing for acid suppression drugs in primary care in Cornwall and the Isles of Scilly
Aliment Pharmacol Ther 1999; 13: 813±817. Survey on repeat prescribing for acid suppression drugs in primary care in Cornwall and the Isles of Scilly R. BOUTET, M. WILCOCK & I. MACKENZIE 1 Department of
More informationNSAIDs Change Package 2017/2018
NSAIDs Change Package 2017/2018 Aim: To Reduce harm to patients from Non-Steroidal Anti-inflammatory Drugs (NSAIDs) in primary care Background A key aim of the Safety in Practice programme is to reduce
More informationNon-steroidal anti-inflammatory drugs and gastrointestinal damage problems and solutions
82 University of Glasgow and Department of Gastroenterology, Royal Infirmary, Glasgow Correspondence to: Professor R I Russell, 28 Ralston Road, Bearsden, Glasgow G61 3BA rirla@aol.com Submitted 26 October
More informationDuodenal Ulcer / Duodenitis
Duodenal Ulcer / Duodenitis Endoscopy Department Patient information leaflet You will only be given this leaflet if you have been diagnosed with duodenitis and/or a duodenal ulcer. The information below
More informationWhat is Bandolier? Balance benefits and harms
What is Bandolier? The first issue of Bandolier, an independent journal about evidence-based healthcare, written by Oxford scientists, (RAM AND HJM) was printed in February 1994. It has appeared monthly
More informationDouble-blind comparison of efficacy and
Annals of the Rheumatic Diseases 1993; 52: 881-885 881 Searle, Box 5110, Chicago, Ill 60680-5110, USA J A Melo Gomes S H Roth J Zeeh G A W Bruyn E M Woods G S Geis Correspondence to: Dr G S Geis Accepted
More informationMitigating GI Risks Associated with the Use of NSAIDs
bs_bs_banner Pain Medicine 2013; 14: S18 S22 Wiley Periodicals, Inc. Mitigating GI Risks Associated with the Use of NSAIDs Mahnaz Momeni, MD,* and James D. Katz, MD Departments of *Rheumatology, Medicine,
More informationEpidemiologic Evidence on the Association Between Peptic Ulceration and Antiinflammatory Drug Use
GASTROENTEROLOGY 1989;96:640-6 Epidemiologic Evidence on the Association Between Peptic Ulceration and Antiinflammatory Drug Use M. J. S. LANGMAN Department of Medicine, Queen Elizabeth Hospital, Birmingham,
More informationSetting The setting was community. The economic study was carried out in the USA.
Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy Griffiths R I, Rabeneck L, Guzman G, Cromwell D M, Strauss M J, Robinson J W, Winston B, Li T, Graham D Y Record Status
More informationthreatening complications of peptic ulceration
Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration C P ARMSTRONG AND A L BLOWER From the Leighton Hospital, Leighton, Crewe, Cheshire Gut, 1987, 28, 527-532 SUMMARY
More informationEnhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine
Br. J. clin. Pharmac. (1989), 28, 581-585 Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine G. K. KITCHINGMAN, P. J. PRICHARD, T. K. DANESHMEND,
More informationHealth Economics 101: PPI prescriptions in the Emergency Room
: PPI prescriptions in the Emergency Room Canadian Optimal Medication Prescribing & Utilization Service (COMPUS) Presented by: Chris Cameron October 26, 2007 What is Health Economics? Health economics
More informationGastric Ulcer / Gastritis
Gastric Ulcer / Gastritis Endoscopy Department Patient information leaflet You will only be given this leaflet if you have been diagnosed with gastritis and/or a gastric ulcer. The information below outlines
More informationProtection of human gastric mucosa against aspirinðenteric coating or dose reduction?
Aliment Pharmacol Ther 1999; 13: 187±193. Protection of human gastric mucosa against aspirinðenteric coating or dose reduction? A. T. COLE*, N. HUDSON*, L. C. W. LIEW*, F. E. MURRAY*, C. J. HAWKEY* & S.
More informationModelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam Tavakoli M
Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam Tavakoli M Record Status This is a critical abstract of an economic
More informationGastrointestinal Tolerability of Ibuprofen Compared with Paracetamol and Aspirin at Over-the-counter Doses
The Journal of International Medical Research 2002; 30: 301 308 Gastrointestinal Tolerability of Ibuprofen Compared with Paracetamol and Aspirin at Over-the-counter Doses P RAMPAL 1, N MOORE 2, E VAN GANSE
More informationAetiology Of Upper Gastrointestinal Bleeding In North- Eastern Nigeria: A Retrospective Endoscopic Study
ISPUB.COM The Internet Journal of Third World Medicine Volume 8 Number 2 Aetiology Of Upper Gastrointestinal Bleeding In North- Eastern Nigeria: A Retrospective Endoscopic S Mustapha, N Ajayi, A Shehu
More informationClinical guideline Published: 13 June 2012 nice.org.uk/guidance/cg141
Acute upper gastrointestinal bleeding in over 16s: management Clinical guideline Published: June 2012 nice.org.uk/guidance/cg141 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationLate mortality in elderly patients surviving acute peptic ulcer bleeding
Gut 1995; 37: 177-181 177 Departments of Therapeutics N Hudson C J Hawkey and Public Health and Epidemiology G Faulkner S J Smith R F A Logan University Hospital, Nottingham Deparment of Medicine, Queen
More informationSetting The setting was primary care. The economic analysis was conducted in Glasgow, UK.
Helicobacter pylori eradication for peptic ulceration: an observational study in a Scottish primary care setting Forrest E H, MacKenzie J F, Stuart R C, Morris A J Record Status This is a critical abstract
More informationWhich peptic ulcer patients bleed?
Gut, 1988, 29, 70-74 Which peptic ulcer patients bleed? K MATTHEWSON, S PUGH, AND T C NORTHFIELD From the Gastroenterology Units, St James Hospital, Balham and University College Hospital, London SUMMARY
More informationPeptic ulcer and non-steroidal anti-inflammatory
Gut, 1986, 27, 929-933 Peptic ulcer and non-steroidal anti-inflammatory agents J M DUGGAN, ANNETTE J DOBSON, H JOHNSON, AND P FAHEY From the Gastroenterology Unit, Royal Newcastle Hospital, and Faculty
More informationIs ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?
ORIGINAL PAPER doi: 10.1111/j.1742-1241.2006.01147.x Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use? N. D. YEOMANS, 1 *L-ESVEDBERG,
More informationFrequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema
Bahrain Medical Bulletin, Vol.24, No.3, September 2002 Frequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema Najeeb S Jamsheer, MD, FRCR* Neelam. Malik, MD, MNAMS** Objective: To
More informationDrug prescribing by GPs in Wales and in England
Journal of Epidemiology and Community Health, 1980, 34, 119-123 Drug prescribing by GPs in Wales and in England DEE A. JONES, P. M. SWEETNAM, AND P. C. ELWOOD From the MRC Epidemiology Unit, Cardiff SUMMARY
More informationImpact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside)
Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside) Note: This paper is based on a report originally produced by Dr
More informationSCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE
SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE The Condition 1. The condition should be an important health problem Colorectal
More informationDatabase of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York.
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling Brown
More informationThe long-term management of patients with bleeding duodenal ulcers
Aliment Pharmacol Ther (1997); 11: 505±510. The long-term management of patients with bleeding duodenal ulcers M. E. MCALINDON, J. S. W. TAYLOR & S. D. RYDER Department of Medicine, University Hospital,
More informationGastrointestinal haemorrhage
Gastrointestinal haemorrhage A common emergency Important cause of mortality and morbidity Case fatality is high (10 20% in the UK) Rockall TA et al. BMJ, 1995. 311(6999): p. 222-6. Williams JG et al.
More informationPRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW
PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Dyspepsia refers to a broad range of symptoms related
More informationQuantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use
Pain 85 (2000) 169±182 www.elsevier.nl/locate/pain Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use Martin R. TrameÁr a, *,
More informationAudit of patients with chest pain presenting to an accident and emergency department over a 6-month period
Archives of Emergency Medicine, 1993, 10, 155-160 Audit of patients with chest pain presenting to an accident and emergency department over a 6-month period N. J. FOTHERGILL, M. T. HUNT & R. TOUQUET Accident
More informationUpper Gastrointestinal Bleeding Among Saudis: Etiology And Prevalence The Riyadh Central Hospital Experience
Upper Gastrointestinal Bleeding Among Saudis: Etiology And Prevalence The Riyadh Central Hospital Experience Mohammed Al-Mofarreh, Facharzt; Yisa M. Fakunle, MD, FRCP (London); Mohammed Al-Moagel, Facharzt
More informationDraft Falls Prevention Strategy
Cheshire West & Chester Council Draft Falls Prevention Strategy 2017-2020 Visit: cheshirewestandchester.gov.uk Visit: cheshirewestandchester.gov.uk 02 Cheshire West and Chester Council Draft Falls Prevention
More informationFactors relevant to the prognosis of chronic
Gut, 1975, 16, 714-718 Factors relevant to the prognosis of chronic gastric ulcer D. W. PIPER, MARGARET GREIG, G. A. E. COUPLAND, ELIZABETH HOBBIN, AND JANE SHINNERS From the Departments of Medicine and
More informationGASTRODUODENAL damage can be seen on endoscopy
Vol. 334 No. 22 TO PREVENT GASTRIC AND DUODENAL ULCERS CAUSED BY NSAIDS 43 FOR THE PREVENTION OF GASTRIC AND DUODENAL ULCERS CAUSED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS ALI S. TAHA, PH.D., NICHOLAS HUDSON,
More informationNon-steroidal anti-inflammatory drugs: who should receive prophylaxis?
Aliment Pharmacol Ther 2004; 20 (Suppl. 2): 59 64. Non-steroidal anti-inflammatory drugs: who should receive prophylaxis? C. J. HAWKEY Wolfson Digestive Diseases Centre, Institute of Clinical Research,
More informationNew Medicine Report (Adopted by the CCG until review and further
New Medicine Report (Adopted by the CCG until review and further DEXIBUPROFEN notice) Document Status Decision made at Suffolk D&TC 7 th September 2006 Traffic Light Decision Double Green Prescriber s
More information2010 National Survey. University College London Hospitals NHS Foundation Trust
National Cancer Patient Experience Programme 2010 National Survey University College London Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme
More informationORIGINAL ARTICLE. Abstract
ORIGINAL ARTICLE Prescription of Nonsteroidal Anti-inflammatory Drugs and Co-prescribed Drugs for Mucosal Protection: Analysis of the Present Status Based on Questionnaires Obtained from Orthopedists in
More informationHealth technology Serological testing and endoscopy with biopsy for suspected peptic ulcer disease.
Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis Fendrick A M, Chernew M E, Hirth R A, Bloom
More informationTHE PENROSE INQUIRY STATEMENT OF OR AILEEN KEEL
PEN.018.0396 THE PENROSE INQUIRY STATEMENT OF OR AILEEN KEEL i. My name is Aileen Margaret Keel. My qualifications are MBChB, FRCP (Glasgow), FRCP (Edinburgh), FRCPath, MFPH. I am currently Deputy Chief
More informationPerforated duodenal ulcer in Reading from 1950 to 1959
Gut, 1969, 1, 454-459 Perforated duodenal ulcer in Reading from 195 to 1959 PAUL CASSELL From the Royal Berkshire Hospital, Reading During the last 15 years there has been an evolution in the management
More informationCosting tool: Osteoarthritis Implementing the NICE guideline on osteoarthritis (CG177)
Putting NICE guidance into practice Costing tool: Osteoarthritis Implementing the NICE guideline on osteoarthritis (CG177) Published: February 2014 This costing report accompanies the clinical guideline
More informationSimon Everett. Consultant Gastroenterologist, SJUH, Leeds. if this is what greets you in the morning, you probably need to go see a doctor
Simon Everett Consultant Gastroenterologist, SJUH, Leeds if this is what greets you in the morning, you probably need to go see a doctor Presentation Audit data and mortality NICE guidance Risk assessment
More informationCharacteristics of selective and non-selective NSAID use in Scotland
Characteristics of selective and non-selective NSAID use in Scotland Alford KMG 1, Simpson C 1, Williams D 2 1 Department of General Practice & Primary Care, The University of Aberdeen. 2 Department of
More informationScottish Medicines Consortium
Scottish Medicines Consortium esomeprazole, 40mg vial of powder for solution for intravenous injection or infusion (Nexium I.V. ) No. (578/09) AstraZeneca 09 October 2009 The Scottish Medicines Consortium
More informationSetting The setting was primary care. The economic study was conducted in Canada.
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment - Helicobacter pylori positive (CADET-Hp) randomised controlled
More informationRole of Helicobacter pylori in ulcer healing and
22 Departments of Gastroenterology G Bianchi Porro F Parente V Imbesi and Rheumatology F Montrone I Caruso L Sacco University Hospital, Milan, Italy Correspondence to: Professor G Bianchi Porro, Gastrointestinal
More informationSetting The setting was secondary care. The economic study was carried out in Hong Kong, China.
Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis You J H, Wong
More informationOmeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer
Aliment Pharmacol Ther 1998; 12: 355±360. Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer G. BIANCHI PORRO, M. LAZZARONI, G. MANZIONNA & M. PETRILLO Gastrointestinal
More information1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?
1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare? Dr Nerys Davies, GPST Ms B. Davies, Specialist Nurse (Heart Failure) Dr J. Taylor, Consultant Cardiologist
More informationSetting The setting was the community. The economic study was carried out in the USA.
Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis Yun H R, Bae S C Record
More informationNSAIDs: Side Effects and Guidelines
NSAIDs: Side Effects and James J Hale FY1 Department of Anaesthetics Introduction The non-steroidal anti-inflammatory drugs (NSAIDs) are a diverse group of drugs that have analgesic, antipyretic and anti-inflammatory
More informationGASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali
GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers
More informationPEPTIC ULCER, NONSTEROID ANTI-INFLAMMATORY DRUGS AND THE RHEUMATIC DISEASES
330 BRITISH JOURNAL OF RHEUMATOLOGY VOL. XXV NO. 4 6. Lindahl BIB, Allander E. Problems in the classification of cause of death diagnoses affecting the reliability of mortality statistics for rheumatoid
More informationWhat Is Peptic Ulcer Disease?
What Is Peptic Ulcer Disease? Peptic ulcer disease is when painful sores form in the lining of the stomach, duodenum (start of the small intestine) or bowels. An ulcer can cause belly pain and, in some
More informationPhysician specialty and the outcomes and cost of admissions for end-stage liver disease Ko C W, Kelley K, Meyer K E
Physician specialty and the outcomes and cost of admissions for end-stage liver disease Ko C W, Kelley K, Meyer K E Record Status This is a critical abstract of an economic evaluation that meets the criteria
More information2010 National Survey. East Kent Hospitals University NHS Trust
National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department
More information2010 National Survey. The North West London Hospitals NHS Trust
National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department
More information2010 National Survey. Royal National Orthopaedic Hospital NHS Trust
National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department
More information2010 National Survey. The Leeds Teaching Hospitals NHS Trust
National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department
More informationPATTERN OF USE OF GASTROPROTECTIVE AGENTS ALONG WITH THE ANTI INFLAMMATORY AND ANALGESICS DRUGS
PATTERN OF USE OF GASTROPROTECTIVE AGENTS ALONG WITH THE ANTI INFLAMMATORY AND ANALGESICS DRUGS K. B. Sanalkumar 1, K. T. Shenoy 2, K. Arun 3, Hema Ilavarasi K. M 4, Venugopalan P.G 5, Leena K. B 6 1Additional
More informationDRUG UTILIZATION STUDIES TO GUIDE BETTER HOSPITAL PHARMACEUTICAL POLICY
DRUG UTILIZATION STUDIES TO GUIDE BETTER HOSPITAL PHARMACEUTICAL POLICY Dr. G. Parthasarathi Professor, Pharmacy Practice JSS University, Mysore 30 October 2011 ACPE6 Beijing, 2011 1 Presentation Outline
More information2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust
National Cancer Patient Experience Programme 2010 National Survey Northern Lincolnshire and Goole Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme
More informationPRESCRIBING SUPPORT TEAM AUDIT: Etoricoxib hypertension safety evaluation
PRESCRIBING SUPPORT TEAM AUDIT: Etoricoxib hypertension safety evaluation DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY This audit has been designed to ensure that patients
More informationThe Colorectal (bowel) Family History Clinic. Information for patients Endoscopy
The Colorectal (bowel) Family History Clinic Information for patients Endoscopy What does the Colorectal Family History Clinic provide? The Family History Clinic provides a chance for you to talk about
More informationPrevalence of gastroduodenal lesions in chronic nonsteroidal anti-inflammatory drug users presenting with dyspepsia at the Kenyatta National Hospital
Research Article Department of Clinical Medicine and Therapeutics, University of Nairobi, Kenya Corresponding author: Dr. G O Oyoo. Email: geomondi@hotmail. com Prevalence of gastroduodenal lesions in
More informationBleeds in Cardiovascular Disease
Preventing Gastrointestinal Bleeds in Cardiovascular Disease Patients t on Aspirin i Joel C. Marrs, Pharm.D., BCPS Clinical Assistant Professor OSU/OHSU College of Pharmacy Pharmacy Practice IX (PHAR 766)
More informationdiclofenac, 75mg/2ml of solution for intravenous injection (Dyloject ) No. (446/08) Javelin Pharmaceuticals UK Ltd
Scottish Medicines Consortium diclofenac, 75mg/2ml of solution for intravenous injection (Dyloject ) No. (446/08) Javelin Pharmaceuticals UK Ltd 11 February 2008 The Scottish Medicines Consortium has completed
More informationSummative Assessment Audit Project. Project Number 02
Summative Assessment Audit Project Project Number 02 AUDIT TITLE: Aspirin and Warfarin prophylaxis of thromboembolism in elderly patients with Atrial Fibrillation. What is the title of your audit project?
More informationTechnology appraisal guidance Published: 28 November 2018 nice.org.uk/guidance/ta547
Tofacitinib for moderately to severelyerely active ulcerative colitis Technology appraisal guidance Published: 28 November 2018 nice.org.uk/guidance/ta547 NICE 2019. All rights reserved. Subject to Notice
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Duexis) Reference Number: CP.PMN.120 Effective Date: 06.01.18 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy
More informationVonoprazan, aspirin and NSAIDs: new era in acid inhibition and gastroprotection
1/5 This site uses cookies. More info Home / Online First Article Text Article menu Commentary Vonoprazan, aspirin and NSAIDs: new era in acid inhibition and gastroprotection Ali S Taha Correspondence
More informationScottish Medicines Consortium
Scottish Medicines Consortium duloxetine 30mg and 60mg capsules (Cymbalta ) No. (285/06) Eli Lilly and Company Limited/Boehringer Ingelheim 4 August 2006 The Scottish Medicines Consortium has completed
More informationApixaban for stroke prevention in atrial fibrillation. August 2010
Apixaban for stroke prevention in atrial fibrillation August 2010 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to
More informationrosuvastatin, 5mg, 10mg, 20mg, film-coated tablets (Crestor ) SMC No. (725/11) AstraZeneca UK Ltd.
rosuvastatin, 5mg, 10mg, 20mg, film-coated tablets (Crestor ) SMC No. (725/11) AstraZeneca UK Ltd. 09 September 2011 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product
More informationRe-Submission. Scottish Medicines Consortium. cilostazol 100mg tablets (Pletal ) No. (86/04) Otsuka. 4 October 2005
Scottish Medicines Consortium Re-Submission cilostazol 100mg tablets (Pletal ) No. (86/04) Otsuka 4 October 2005 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product
More informationPrevention of Acute NSAID-Induced Gastroduodenal Damage: Which Strategy is the Best?
Prevention of Acute NSAID-Induced Gastroduodenal Damage: Which Strategy is the Best? Shaden Salamae MD a, Meir Antopolsky MD a, Ruth Stalnikowicz MD a * Department of Emergency Medicine, Hadassah University
More informationA study on clinical profile and risk factors in drug induced UGI bleeding
Original Research Article A study on clinical profile and risk factors in drug induced UGI bleeding S. Appandraj 1*, V. Sakthivadivel 2 1,2 Associate Professor, Dept. of General Medicine, Karpaga Vinayaga
More informationROYAL COLLEGE OF PSYCHIATRISTS RAPID EVIDENCE REVIEW OF EVIDENCE-BASED TREATMENT FOR GAMBLING DISORDER IN BRITAIN
ROYAL COLLEGE OF PSYCHIATRISTS RAPID EVIDENCE REVIEW OF EVIDENCE-BASED TREATMENT FOR GAMBLING DISORDER IN BRITAIN Dr Henrietta BOWDEN-JONES, Consultant Addiction Psychiatrist, National Problem Gambling
More informationOutcome following surgery for colorectal cancer
Outcome following surgery for colorectal cancer Colin S McArdle* and David J Hole *University Department of Surgery, Glasgow Royal Infirmary, Glasgow and Department of Public Health, University of Glasgow,
More information1 Emergency Medicine Academic Group, Department of Cardiovascular Sciences, University of Leicester, UK.
Title: A week of pain in the Emergency Department Authors: Thornton HS 1, Reynolds J 1, Coats TJ 1 1 Emergency Medicine Academic Group, Department of Cardiovascular Sciences, University of Leicester, UK.
More informationDiagnostic laparoscopy: procedure-specific information
PATIENT INFORMATION Diagnostic laparoscopy: procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the British Association of
More informationEpidemiology of diverticulosis and diverticular disease. Alfredo Papa U.O.C. Medicina Interna e Gastroenterologia, C.I. Columbus
Epidemiology of diverticulosis and diverticular disease Alfredo Papa U.O.C. Medicina Interna e Gastroenterologia, C.I. Columbus Summary Burden of disease on health care resources (outpatients visits, admissions,
More information